These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38027111)

  • 1. Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis.
    Pan Q; Chen HQ; Chow WC; Zhou HP
    Front Endocrinol (Lausanne); 2023; 14():1308860. PubMed ID: 38027111
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential epigenetic mechanism in non-alcoholic Fatty liver disease.
    Sun C; Fan JG; Qiao L
    Int J Mol Sci; 2015 Mar; 16(3):5161-79. PubMed ID: 25751727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.
    Wajsbrot NB; Leite NC; Salles GF; Villela-Nogueira CA
    World J Gastroenterol; 2022 Jul; 28(25):2890-2899. PubMed ID: 35978876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Epigenetics in the Progression of Non-Alcoholic Fatty Liver Disease.
    Aguilar-Olivos NE; Oria-Hernández J; Ponciano-Rodríguez G; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Mini Rev Med Chem; 2015; 15(14):1187-94. PubMed ID: 26156419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease.
    Panera N; Gnani D; Crudele A; Ceccarelli S; Nobili V; Alisi A
    World J Gastroenterol; 2014 Nov; 20(41):15079-86. PubMed ID: 25386056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic-associated Fatty Liver Disease Regulation through Nutri Epigenetic Methylation.
    Rivera-Aguirre J; López-Sánchez GN; Chávez-Tapia NC; Uribe M; Nuño-Lámbarri N
    Mini Rev Med Chem; 2023; 23(17):1680-1690. PubMed ID: 36718062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in non-alcoholic fatty liver disease.
    Lee J; Kim Y; Friso S; Choi SW
    Mol Aspects Med; 2017 Apr; 54():78-88. PubMed ID: 27889327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrients, Genetic Factors, and Their Interaction in Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease.
    Lombardi R; Iuculano F; Pallini G; Fargion S; Fracanzani AL
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver disease.
    Polyzos SA
    Minerva Endocrinol; 2017 Jun; 42(2):89-91. PubMed ID: 27792216
    [No Abstract]   [Full Text] [Related]  

  • 10. Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition.
    Lee JH; Friso S; Choi SW
    Nutrients; 2014 Aug; 6(8):3303-25. PubMed ID: 25195642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease establishment and progression: genetics and epigenetics as relevant modulators of the pathology.
    Pansa CC; Molica LR; Moraes KCM
    Scand J Gastroenterol; 2023 May; 58(5):521-533. PubMed ID: 36426638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.
    Juanola O; Martínez-López S; Francés R; Gómez-Hurtado I
    Int J Environ Res Public Health; 2021 May; 18(10):. PubMed ID: 34069012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated Epigenetic Modifications in the Pathogenesis of NAFLD-HCC.
    Zhao F
    Adv Exp Med Biol; 2018; 1061():79-93. PubMed ID: 29956208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics: An emerging field in the pathogenesis of nonalcoholic fatty liver disease.
    Ashraf NU; Altaf M
    Mutat Res Rev Mutat Res; 2018; 778():1-12. PubMed ID: 30454678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of genetics and metabolism in non-alcoholic fatty liver disease.
    Abenavoli L; Pellicano R; Boccuto L
    Panminerva Med; 2018 Jun; 60(2):41-43. PubMed ID: 29442484
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease.
    Aggeletopoulou I; Kalafateli M; Tsounis EP; Triantos C
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction-associated fatty liver disease: advances in genetic and epigenetic implications.
    Pirola CJ; Sookoian S
    Curr Opin Lipidol; 2022 Apr; 33(2):95-102. PubMed ID: 34966133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and epigenetics of NAFLD and NASH: Clinical impact.
    Eslam M; Valenti L; Romeo S
    J Hepatol; 2018 Feb; 68(2):268-279. PubMed ID: 29122391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical Importance of Non-alcoholic Fatty Liver Diseases. Topics: II. Complexity in pathogenesis of nonalcoholic fatty liver disease].
    Ikejima K
    Nihon Naika Gakkai Zasshi; 2016 Jan; 105(1):15-24. PubMed ID: 27266039
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.
    Liu XL; Cao HX; Fan JG
    J Dig Dis; 2016 Nov; 17(11):708-715. PubMed ID: 27628945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.